EP
IRWD icon

Essential Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Essential Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.1K Buy
6,330
+98
+2% +$409 0.01% 833
2026
Q2 		$26.2K Sell
6,232
-15,870
-72% -$61.2K 0.01% 805
2026
Q1 		$77.6K Buy
22,102
+21
+0.1% +$86 0.03% 482
2025
Q4 		$74.4K Buy
22,081
+153
+0.7% +$397 0.02% 517
2025
Q3 		$28.7K Buy
21,928
+7,469
+52% +$7.73K 0.01% 773
2025
Q2 		$10.4K Buy
+14,459
New +$11.4K ﹤0.01% 832

Other funds holding IRWD

Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners's IRWD Position: Q3 2026 in Review

Essential Partners increased its Ironwood Pharmaceuticals (IRWD) stake by 1.6% in Q3 2026, buying an estimated $409 and bringing the position to 6,330 shares worth $25.1K. The position accounts for 0.01% of the portfolio, ranked #833.

Essential Partners first reported a position in IRWD in Q2 2025 and has held it in 6 quarters since. The position peaked at $77.6K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Essential Partners held 6,330 shares of Ironwood Pharmaceuticals worth $25.1K as of Q3 2026.
  • Essential Partners bought 98 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $409.
  • Ironwood Pharmaceuticals made up 0.01% of Essential Partners's portfolio in Q3 2026, its #833 holding.
  • Essential Partners first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Ironwood Pharmaceuticals position peaked at $77.6K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.